A Texas ban on smokable hemp products hit another roadblock in court last week when a state judge barred officials from enforcing the prohibition until an industry challenge can be heard in court.
MindMed Catches Fire, Seeks To Up-List On NASDAQ
MindMed stock has spiked higher by over 30%, on big volume. New investor focus on the deepest clinical research program in the industry.
PharmaDrug Inc. Closes Transaction to Acquire First Smart Shop in the Netherlands, Initiates Major Push to Acquire Best of Breed High Traffic Locations
PharmaDrug will assume control of its first Super Smart psychedelics store on October 1st.
Psychedelics Stock Warrants Offer Interesting Leverage Play
Psychedelic stock warrants that are currently out of the money COULD produce big returns for investors.
Revive Therapeutics Provides Corporate Update on its Psychedelics Therapeutics Programs
Revive's corporate update centers on psilocybin research on a new delivery system and addiction treatment.
Cannabis-based packaging and paper could reduce waste, promote sustainability
Cannabis businesses have long struggled with the excessive packaging their products are required to use, employing extra layers of plastic and paper to ensure that flower or vape products are childproof and don’t fall into the wrong hands.
New Marijuana Coalition Unveils Plan To Legalize Interstate Cannabis Commerce
A coalition of advocacy groups and marijuana businesses have unveiled a unique plan to legalize interstate cannabis commerce regardless of ongoing federal prohibition.
Nebraska Activists Submit 15k Signatures to Establish ‘Legal Marijuana Now’ Party
Nebraska activists have turned in 15,000 signatures to establish the Legal Marijuana Now party in the state, four years after falling short due to a lack of valid signatures, the Lincoln Journal-Star reports.
Numinus Announces Listing of Warrants
Numinus warrants have an exercise price of CAD$0.35 and are valid until September 10, 2022.
MindMed Submits Application For NASDAQ Up-Listing, Appoints Canaccord Genuity As Financial Advisor
MindMed Inc has applied to up-list on the NASDAQ.
Mind Cure Targets Multi-Billion Dollar Sweet-Spot in Life Sciences
The road to psychedelic drug success leads through functional mushrooms.
